Osteoporosis 2000-2010

Acta Orthopaedica Scandinavica, Supplement

Volumn 69, Issue 281, 1998, Pages 21-27

  Lips, Paul ^a   Cooper, Cyrus ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; ESTROGEN; ETIDRONIC ACID; PARATHYROID HORMONE DERIVATIVE; RALOXIFENE; VITAMIN D;

BONE DENSITY; BONE MINERAL; CONFERENCE PAPER; FEMALE; HIP FRACTURE; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; RISK ASSESSMENT; VERTEBRA FRACTURE; ARTICLE; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR;

BONE DENSITY; FEMALE; HIP FRACTURES; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0031714578     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Melton LJ, Chrischilles EA, Cooper C et al. How many women have osteoporosis? J Bone Miner Res 1992; 7: 1005-10.
2. Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck of elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309: 691-5.
3. Johnell O, Gullberg B, Allander E et al. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporosis Int 1992; 2: 298-302.
4. Cooper C, Melton LJ. Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J eds. Osteoporosis. Academic Press Inc, San Diego, 1996: 419-34.
5. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993; 137: 1001-5.
6. Cooper C, Barker DJP. Risk factors for hip fracture. New Eng J Med 1995; 332: 814-5.
7. Cooper C, O'Neill T, Silman AJ. The epidemiology of vertebral fractures. Bone 1993; 14: S89-S97.
8. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ and the European Vertebral Osteoporosis Study Group. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11: 1010-8.
9. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 341: 72-75; 1993.
10. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series no. 843. Geneva: World Health Organization, 1994:1-129.
11. Simmons A, Simpson DE, O'Doherty MJ, Barrington S, Coakley AJ. The effect of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry. Osteoporosis Int 1997; 7: 200-6.
12. Ahmed AIH, Blake GM, Rymer JM, Fogelman I. Screening for osteopenia and osteoporosis.: Do the accepted normal values lead to over diagnosis? Osteoporosis Int 1997; 7: 432-8.
13. Grampp S, Genant HK, Mathur A et al. Comparisons of non invasive bone mineral measurements in assessing age-related loss, fracture discrimination and diagnostic classification. J Bone Miner Res 1997; 12: 697-711.
14. Lips P, Epidemiology and predictors of fractures associated with osteoporosis Am J Med 1997; 103(2A): 3S-11S.
15. Ross PD, Davis JW, Epstein R, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence. Ann Intern Med 1991; 114: 919-23.
16. Owen RA, Melton LJ, Illstrup DM, Johnson KA, Riggs BL. Colles fracture and subsequent hip fracture risk. Clin Orthop 1982; 171: 37-43.
17. Cooper C, Kotowicz M, Atkinson EJ, O'Fallon WM, Riggs BL, Melton LJ. Risk of limb fractures among men and women with vertebral fractures. In: Papapoulos SE, et al (ed). Osteoporosis 1996. Elsevier Science BV, Amsterdam, 1996: pp 101-104.
18. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporosis Int 1997; 7: 390-406.
19. Cummings S, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
20. Silman AJ, O'Neill TW, Cooper C, Kanis J, Fedlsenberg D, and the EVOS Study Group. Influence of physical activity on vertebal deformity in males and females: results from the European Vertebral Osteoporosis Study. J Bone Miner Res; in press.
21. O'Neill TW, Silman AJ, Naves-Diaz M, Cooper C, Kanis J, Felsenberg D, and the EVOS Study Group. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. Osteoporosis Int 1997; 7: 72-8.
22. Cooper C, O'Neill TW, Egger P et al. Vertebral deformities: clinical impact and relation to fractures at other sites. American Society for Bone and Mineral Research, Baltimore, 1995. Abstract: J Bone Miner Res 1995; 10: S145 (abstract).
23. Garnero P, Hausherr E, Chapuy M-C,et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996; 11: 1531-8.
24. Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996; 348: 145-9.
25. Graafmans WC, Ooms ME, Hofstee HMA, et al. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996; 143: 1129-36.
26. Eastell R. Practical management of the patient with osteoporotic vertebral fracture. PJ Meunier, editor "Osteoporosis, diagnosis and management" Martin Dunitz, London 1998, pp 175-90.
27. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
28. Colditz GA, Hankinson SE, Hunter DJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-93.
29. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: A comparative study of exercise, calcium supplementation, and hormone replacement therapy. N Engl J Med 1991; 325: 1189-95.
30. Elders PJM, Lips P, Netelenbos JC, et al. Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 1994; 9: 963-70.
31. Dawson-Hughes B. Calcium, vitamin D and vitamin D metabolites. In: Osteoporosis (Eds. SE Papapoulos, P Lips, HAP Pols, CC Johnston, PD Delmas). 96 International Congres Series 1118 Excerpta Medica 1996 Amsterdam, pp 299-303.
32. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 1995; 80: 1052-8.
33. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
34. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124: 400-6.
35. Harris ST, Watts NB, Jackson RD et al. Four year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis Am J Med 1993; 95: 557-67.
36. Black DM, Cummings SR, Karpf DB et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 1535-41.
37. Hosking D, Chilvers CEO, Christiansen C et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998; 338: 485-92.
38. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995; 99: 235-42.
39. Delmas PD, Bjarnason NH, Mitlak BH et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337: 1641-7.
40. Meunier PJ Bone forming agents. SE Papapoulos et al editors Osteoporosis '96 International Congres Series 1118 Excerpta Medica Amsterdam 1996, pp 305-14.
41. Lauritzen JB, Petersen MM, Lund B. Effect of external hip protectors on hip fractures. Lancet 1993; 341: 11-3.
42. Glüer CC for the International QUS Consensus Group; Quantitative ultrasound techniques for the assessment of osteoporosis. J Bone Miner Res 1997; 12: 1280-8.
43. Hans D, Dargent-Molina P, Schott A et al. Ultrasonic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996; 348: 511-4.
44. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
45. Uitterlinden AG, Burger H, Huang Q et al. Relation of alleles of the collagen type IA1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Eng J Med 1998; 338: 1016-21.
46. Cooper C, Fall C, Egger P, Hobbs R, Eastell R, Barker D. Growth in infancy and bone mass in later life. Ann Rheum Dis 1997; 56: 17-21.
47. Lips P. Prevention of hip fractures: drug therapy. Bone 1996; 18: 159S-163S.
48. Ooms ME, Vlasman P, Lips P, et al. The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int 1994; 4: 6-10.
49. Tinetti ME, Baker DI, Mc Avay G et al. A multifactional intervention to reduce the risk of falling among elderly people living in the community. N Eng J Med 1994; 331: 821-7.
50. Lips P, Cooper C, Agnusdei et al. Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporosis Int 1997; 7: 36-8.